196 related articles for article (PubMed ID: 22400488)
1. Adrenomedullin expression in epithelial ovarian cancers and promotes HO8910 cell migration associated with upregulating integrin α5β1 and phosphorylating FAK and paxillin.
Deng B; Zhang S; Miao Y; Han Z; Zhang X; Wen F; Zhang Y
J Exp Clin Cancer Res; 2012 Mar; 31(1):19. PubMed ID: 22400488
[TBL] [Abstract][Full Text] [Related]
2. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
[TBL] [Abstract][Full Text] [Related]
3. MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin β1 pathway.
Chen CH; Shyu MK; Wang SW; Chou CH; Huang MJ; Lin TC; Chen ST; Lin HH; Huang MC
Gynecol Oncol; 2016 Jan; 140(1):131-7. PubMed ID: 26616226
[TBL] [Abstract][Full Text] [Related]
4. Tripartite Motif-Containing Protein 59 (TRIM59) Promotes Epithelial Ovarian Cancer Progression via the Focal Adhesion Kinase(FAK)/AKT/Matrix Metalloproteinase (MMP) Pathway.
Zhang P; Zhang H; Wang Y; Zhang P; Qi Y
Med Sci Monit; 2019 May; 25():3366-3373. PubMed ID: 31062766
[TBL] [Abstract][Full Text] [Related]
5. PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer.
Zhang W; Liu R; Tang C; Xi Q; Lu S; Chen W; Zhu L; Cheng J; Chen Y; Wang W; Zhong J; Deng Y
Int J Biol Macromol; 2016 Apr; 85():405-16. PubMed ID: 26772918
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
Ma Z; Wang X; He J; Xia J; Li Y
PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of microtubule-associated protein 1 light chain 3B via small-interfering RNA or 3-methyladenine impairs hypoxia-induced HO8910PM and HO8910 epithelial ovarian cancer cell migration and invasion and is associated with RhoA and alterations of the actin cytoskeleton.
Tang Z; Zhang N; Di W; Li W
Oncol Rep; 2015 Mar; 33(3):1411-7. PubMed ID: 25607473
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.
Zhang Y; Xu Y; Ma J; Pang X; Dong M
Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613
[TBL] [Abstract][Full Text] [Related]
9. Adrenomedullin Up-regulates the Expression of Vascular Endothelial Growth Factor in Epithelial Ovarian Carcinoma Cells via JNK/AP-1 Pathway.
Chen Q; Chen P; Pang X; Hu Y; Zhang Y
Int J Gynecol Cancer; 2015 Jul; 25(6):953-60. PubMed ID: 26098087
[TBL] [Abstract][Full Text] [Related]
10. Lidocaine inhibits the metastatic potential of ovarian cancer by blocking Na
Liu C; Yu M; Li Y; Wang H; Xu C; Zhang X; Li M; Guo H; Ma D; Guo X
Cancer Med; 2021 Jan; 10(1):337-349. PubMed ID: 33280262
[TBL] [Abstract][Full Text] [Related]
11. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
[TBL] [Abstract][Full Text] [Related]
14. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
15. Dickkopf-4 is frequently overexpressed in epithelial ovarian carcinoma and promotes tumor invasion.
Wang S; Wei H; Zhang S
BMC Cancer; 2017 Jun; 17(1):455. PubMed ID: 28666421
[TBL] [Abstract][Full Text] [Related]
16. Basic fibroblast growth factor upregulates adrenomedullin expression in ovarian epithelial carcinoma cells via JNK-AP-1 pathway.
Zhang Y; Zhang S; Shang H; Pang X; Zhao Y
Regul Pept; 2009 Oct; 157(1-3):44-50. PubMed ID: 19616043
[TBL] [Abstract][Full Text] [Related]
17. The exosomal integrin α5β1/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration.
Li X; Tang M; Zhu Q; Wang X; Lin Y; Wang X
Cell Oncol (Dordr); 2020 Apr; 43(2):263-277. PubMed ID: 32080801
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.
Wangpu X; Lu J; Xi R; Yue F; Sahni S; Park KC; Menezes S; Huang ML; Zheng M; Kovacevic Z; Richardson DR
Mol Pharmacol; 2016 May; 89(5):521-40. PubMed ID: 26895766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
